SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-14-006472
Filing Date
2014-04-11
Accepted
2014-04-11 08:49:02
Documents
4
Period of Report
2014-05-22
Effectiveness Date
2014-04-11

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A furx20140403_def14a.htm DEF 14A 701049
2 pc2.jpg GRAPHIC 102203
3 pc1.jpg GRAPHIC 268549
4 drrsignature.jpg GRAPHIC 10098
  Complete submission text file 0001437749-14-006472.txt   1227289
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34641 | Film No.: 14758741
SIC: 2834 Pharmaceutical Preparations